Growth Metrics

Oruka Therapeutics (ORKA) EPS (Basic) (QoQ) (2010 - 2024)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 -28.57%
Mar 31, 2024 -75.00%
Dec 31, 2023 20.00%
Sep 30, 2023 0.00%
Jun 30, 2023 -11.11%
Mar 31, 2023 -12.50%
Dec 31, 2022 50.00%
Sep 30, 2022 27.27%
Jun 30, 2022 4.35%
Mar 31, 2022 42.50%
Dec 31, 2021 -21.21%
Sep 30, 2021 2.94%
Jun 30, 2021 -3.03%
Mar 31, 2021 45.90%
Dec 31, 2020 -84.85%
Sep 30, 2020 54.79%
Jun 30, 2020 12.05%
Mar 31, 2020 -20.29%
Dec 31, 2019 9.21%
Sep 30, 2019 33.33%
Jun 30, 2019 38.71%
Mar 31, 2019 3.12%
Dec 31, 2018 6.80%
Sep 30, 2018 24.82%
Jun 30, 2018 24.10%
Mar 31, 2018 -961.76%
Dec 31, 2017 12.82%
Sep 30, 2017 33.90%
Jun 30, 2017 -22.92%
Mar 31, 2017 -4.35%
Dec 31, 2016 9.80%
Sep 30, 2016 -18.60%
Jun 30, 2016 -7.50%
Mar 31, 2016 -42.86%
Dec 31, 2015 9.68%
Sep 30, 2015 55.07%
Jun 30, 2015 24.18%
Mar 31, 2015 -4.60%
Dec 31, 2014 -14.47%
Sep 30, 2014 -590.91%
Jun 30, 2014 15.38%
Mar 31, 2014 -62.50%
Dec 31, 2013 50.00%
Sep 30, 2013 75.38%
Jun 30, 2013 -85.71%
Mar 31, 2013 -20.69%
Dec 31, 2012 29.27%
Sep 30, 2012 28.07%
Jun 30, 2012 17.39%
Mar 31, 2012 75.62%
Dec 31, 2011 -1,564.71%
Sep 30, 2011 -666.67%
Jun 30, 2011 112.00%
Mar 31, 2011 -38.89%
Dec 31, 2010 25.00%
Sep 30, 2010 7.69%